| Description |
1 online resource |
| Physical Medium |
polychrome |
| Description |
text file |
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Preface; Chapter 1; Cefaclor: Clinical, Biochemical, Analytical and Stability Aspects; Abstract; 1. Introduction; 1.1. Cephalosporin Generations; 1.2. Cefaclor; 1.2.1. Mode of Action; 1.2.2. Anti-Bacterial Activity; 1.2.2.1. Gram Positive Spectra; 1.2.2.2.Gram Negative Spectra; 2. Indications; 2.1. Respiratory Tract Infections; 2.2. Urinary Tract Infections; 2.3. Skin and Soft Tissue Infections (SSTIs); 2.4. Blood Stream Infections; 2.5. Intra-Abdominal Infections; 2.6. Other Indications; 2.7. Immune System; 3. Contraindications; 3.1. Warning and Precautions; 3.2. Renal Cleareance |
|
3.3. Pregnancy and Nursing Mother4. Side Effects and Adverse Effects; 4.1. Gastrointestinal Effects; 4.2. Hypersensitivity; 4.3. Hepatic Effects; 4.4. Blood Disorders; 4.5. Kidney Disorders; 4.6. Superinfection; 5. Drug-Drug Interactions; 6. Pharmacokinetics; 6.1. Absorption; 6.2. Distribution; 6.3. Metabolism; 6.4. Elimination; 7. Resistance; 8. Dosage; 9. Analysis of Cefaclor; 10. Stability of Cefaclor; 11. Sustained Release Cefaclor; Conclusion; References; Chapter 2; Microbial Responses and Resistance to Chloramphenicol; Abstract; Introduction; Antibiotic Activity of Chloramphenicol |
|
Gene Mutations for Chloramphenicol ResistanceStress-Induced Mutagenesis; Chloramphenicol Exporters; Enzymatic Inactivation of Chloramphenicol; Chloramphenicol 3-O-Acetyltransferase; Chloramphenicol Application; Conclusion; References; Biographical Sketches; Chapter 3; Cetirizine: Indications, Contraindications and Adverse Effects; Abstract; Introduction; Chemistry; Pharmacodynamics; Pharmacokinetics; Absorption and Distribution; Metabolism and Elimination; Indications; Contraindications; Adverse Effects; Conclusion; References; Chapter 4 |
|
Alteration of Perforin Status Caused by Asbestos Exposure in CTL and NK CellsAbstract; 1. Introduction; 2. Perforin in NK Cell Line Continuously Exposed to Asbestos Fibers; 3. Perforin in CTLs; 3.1. Production of Perforin and Degranulation; 3.2. Granzyme B Production and CD45RA Negative Cells; 3.3. Perforin, CTLs and Asbestos Exposure; 4. Reduced Anti-Tumor Immunity in Other Immune Cells; 5. Summary; Acknowledgments; References; Chapter 5 |
|
Deregulation of Platelet-Derived Growth Factor (PDGF)-Dependent Cell Proliferation through Potentiated and Sustained Activation of (1-Integrin, Induced by Tenascin-C-Derived Peptide TNIIIA2Abstract; Abbreviations; 1. Introduction; 2. About Our Research; 2.1. Hyperstimulation of PDGF-Dependent Proliferation in Nontransformed Fibroblasts by Peptide TNIIIA2; 2.2. Pro-Adhesive Nature of TNIIIA2; 2.3. Molecular Mechanism Underlying Hyperstimulation of PDGF-dependent Cell Proliferation by TNIIIA2; 2.4. Physiological Relevance of TNIIIA2-Induced Hyperstimulation of Cell Proliferation |
| Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
Clinical medicine.
|
|
Clinical medicine. |
|
Biology.
|
|
Biology. |
| Genre/Form |
Electronic books.
|
| ISBN |
9781536121933 (electronic book) |
|
1536121932 (electronic book) |
|
9781536121780 |
|
